Cage The Elephant have announced a 2027 U.K. and European tour, dubbed the "Dying In Reverse" tour. "Dying In Reverse" is the ...

Context Therapeutics Inc. , a clinical-stage biopharmaceutical company, announcement on Wednesday the dosing of the first patient in the Phase 1 trial for CT-202 in treating Necti ...

On Wednesday, Omnicom Group Inc. ( OMC ), an advertising agency, announced that Troy Ruhanen, President and Chief Executive Officer of Omnicom Advertising, has taken the decision to retire from his ...

Trinity Biotech plc ( TRIB) announced that its Trinovium subsidiary has signed a contract with Red Team Investments (RTI) to develop and deploy advanced direct-to-chip liquid cooling solutions for AI, ...

Under UK takeover rules, Circle8 must by 5 p.m. on October 7, 2026, either announce a firm intention to make an offer or state it does not intend to do so, in which case the announcement will be ...

Serina Therapeutics Inc. (SER), a clinical-stage biotechnology company, on Wednesday reported the completion of a blinded review evaluating Cohort 1 data from the Phase 1b trial for SER-252 in ...

Femasys Inc. ( FEMY) announced a partnership with CapexMD to expand patient access to its FemaSeed-led fertility portfolio through dedicated financing solutions. The collaboration is intended to help ...

Ampligen is AIM's lead investigational product and is a double-stranded RNA (dsRNA) and highly selective TLR3 agonist immunomodulator being developed for late-stage pancreatic cancer. AIM ImmunoTech ...